E
ENGENE HOLDINGS INC. COMMON STOCK
NASDAQ: ENGN (enGene Therapeutics Inc.)
最近更新时间: 2小时之前1.96
0.04 (2.08%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | enGene Therapeutics Inc. | 混合的 | 看涨 |
AIStockmoo 评分
2.0
| 分析师共识 | NA |
| 内部交易活动 | 3.0 |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 2.00 |
|
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 13.63% |
| 机构持股比例 | 77.57% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Siren, L.L.C. | 30 Jun 2026 | 6,256,662 |
| Nextech Invest Ltd. | 30 Jun 2026 | 2,324,943 |
| Acorn Capital Advisors, Llc | 30 Jun 2026 | 1,271,257 |
| Sr One Capital Management, Lp | 30 Jun 2026 | 747,750 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| GROSSMAN WILLIAM | 2.05 | - | 5,102 | 10,459 |
| 累积净数量 | 5,102 | |||
| 累积净值 ($) | 10,459 | |||
| 累积平均购买 ($) | 2.05 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| GROSSMAN WILLIAM | 职员 | 22 Sep 2026 | 买 (+) | 5,102 | 2.05 | 10,459 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合